Latest News

Dow Jones Newswires: GSK says U.S. FDA approves Boostrix for immunization during pregnancy



said Monday that the U.S. Food and Drug Administration has approved Boostrix for immunization during the third trimester of pregnancy to help prevent pertussis, or whooping cough, in infants under two months old.

The U.K.-based maker of cancer and asthma medications said the vaccine–which is given during pregnancy–passes antibodies to babies before birth. The vaccine is also indicated against tetanus, diphtheria and pertussis in individuals aged 10 years and older, GSK said.

Boostrix is currently approved in more than 80 countries including most EU countries, as well as Canada, Australia and New Zealand, as a vaccine for tetanus, diphtheria and pertussis, the company said.

Write to Anthony O. Goriainoff at

: A majority of Republicans prefer state-level abortion policies, even though they don’t support Roe v. Wade. Here’s why.

Previous article

Aussie Down on Risk Aversion, Poor Service Data

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News